Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $17.75 | 5.5K |
| Pathgroup Labs, Llc | $17.73 | 1.2K |
| Mako Medical Laboratories, Llc | $17.64 | 219 |
| Quest Diagnostics Clinical... | $17.78 | 171 |
| Andor Labs | $17.78 | 105 |
| Laboratory Corporation Of America... | $17.78 | 27 |
| Laboratory Corporation Of America... | $17.60 | 16 |
North Carolina Pricing in Context
In North Carolina, CPT code 86665 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid) carries an average Medicare payment of $17.73 — 0% above the national benchmark of $17.73. 13 providers across the state submitted claims for this procedure in 2023, performing 7.3K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $102.38, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in North Carolina lands near $38.66, with self-pay cash prices typically around $41.46. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost in North Carolina?
The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in North Carolina is $17.73, which is 0% above the national average of $17.73. Providers in NC typically bill $102.38 for this procedure.
What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost with insurance in North Carolina?
With commercial insurance in North Carolina, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs an estimated $38.66. Without insurance, the estimated cash price is $41.46. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in North Carolina?
13 providers in North Carolina billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in 2023, performing 7.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cheaper in North Carolina than the national average?
No — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs 0% above the national average in North Carolina. The state average Medicare payment is $17.73 compared to $17.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.